FNPFX
Price
$65.05
Change
-$0.40 (-0.61%)
Updated
Sep 20 closing price
GLVCX
Price
$66.89
Change
-$0.37 (-0.55%)
Updated
Sep 20 closing price
Ad is loading...

FNPFX vs GLVCX

Header iconFNPFX vs GLVCX Comparison
Open Charts FNPFX vs GLVCXBanner chart's image
American Funds New Perspective F3
Price$65.05
Change-$0.40 (-0.61%)
VolumeN/A
CapitalizationN/A
Invesco Global Focus C
Price$66.89
Change-$0.37 (-0.55%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
FNPFX vs GLVCX Comparison Chart
Loading...
VS
FNPFX vs. GLVCX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FNPFX is a StrongBuy and GLVCX is a StrongBuy.

FUNDAMENTALS
Fundamentals
FNPFX has more cash in the bank: 145B vs. GLVCX (578M). FNPFX pays higher dividends than GLVCX: FNPFX (1.11) vs GLVCX (0.00). FNPFX was incepted earlier than GLVCX: FNPFX (8 years) vs GLVCX (17 years). FNPFX is a more actively managed with annual turnover of: 17.00 vs. GLVCX (9.00). GLVCX has a lower initial minimum investment than FNPFX: GLVCX (1000) vs FNPFX (1000000). GLVCX annual gain was more profitable for investors over the last year : 31.29 vs. FNPFX (23.29). FNPFX return over 5 years is better than : 47.04 vs. GLVCX (36.59).
FNPFXGLVCXFNPFX / GLVCX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence8 years17 years-
Gain YTD16.36915.887103%
Front LoadN/AN/A-
Min. Initial Investment10000001000100,000%
Min. Initial Investment IRAN/AN/A-
Net Assets145B578M25,087%
Annual Yield % from dividends1.110.00-
Returns for 1 year23.2931.2974%
Returns for 3 years-3.42-13.5025%
Returns for 5 years47.0436.59129%
Returns for 10 yearsN/A68.57-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
WEC94.720.94
+1.00%
WEC Energy Group
FET16.610.16
+0.97%
Forum Energy Technologies
BGC9.77-0.06
-0.61%
BGC Group
TXMD1.70-0.02
-1.16%
TherapeuticsMD
CRON2.15-0.07
-3.36%
Cronos Group